Yu Wei
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 4
-
- Ferroptosis and cancer prognosis 2
- Blood properties and coagulation 1
- Co-authors
- Ming Hou (7 shared papers)Jun Peng (5 shared papers)Yawen Wang (2 shared papers)Jingxia Wang (2 shared papers)Guoqiang Liu (2 shared papers)Fang Zhou (2 shared papers)Xuena Liu (3 shared papers)Xinguang Liu (3 shared papers)
In The Last Decade
Yu Wei
15 papers receiving 409 citations
Peers
Comparison fields: 5 of 55
- Hematology 311
- Genetics 61
- Pathology and Forensic Medicine 72
- Nephrology 25
- Immunology and Allergy 21
Countries citing papers authored by Yu Wei
This map shows the geographic impact of Yu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wei more than expected).
Fields of papers citing papers by Yu Wei
This network shows the impact of papers produced by Yu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wei. The network helps show where Yu Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 150 | |
| 2 | 2016 | 76 | |
| 3 | 2016 | 59 | |
| 4 | 2016 | 54 | |
| 5 | 2016 | 24 | |
| 6 | 2015 | 17 | |
| 7 | 2024 | 7 | |
| 8 | 2016 | 6 | |
| 9 | Validation of four different risk stratification models in patients undergoing heart valve surgery in a single center in China. | 2011 | 5 |
| 10 | 2025 | 4 | |
| 11 | Lipid-lowering efficacy and safety of varying doses of Simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study. | 2003 | 4 |
| 12 | [Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement--3 000 Cases Follow-up]. | 2016 | 4 |
| 13 | [The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia]. | 2011 | 4 |
| 14 | 2014 | 2 | |
| 15 | 2024 | 2 |
About Yu Wei
Yu Wei is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 15 papers that have together received 418 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (7 papers), Blood groups and transfusion (4 papers), Ferroptosis and cancer prognosis (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Immune cells in cancer (2 papers), Blood properties and coagulation (1 paper), Epigenetics and DNA Methylation (1 paper) and Heparin-Induced Thrombocytopenia and Thrombosis (1 paper). The work is most often cited by research in Hematology (311 citations), Genetics (61 citations), Pathology and Forensic Medicine (72 citations), Nephrology (25 citations) and Immunology and Allergy (21 citations). Yu Wei has collaborated with scholars based in China and Canada. Frequent co-authors include Ming Hou, Jun Peng, Yawen Wang, Jingxia Wang, Guoqiang Liu, Fang Zhou, Xuena Liu, Xinguang Liu, Xuebin Ji and Zhengcheng Wang. Their work appears in journals such as Blood, Seminars in Hematology, Acta Pharmacologica Sinica, Journal of Food Biochemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.